Skip to main content
Log in

A Functional Proteomics Screen of Proteases In Colorectal Carcinoma

  • Original Articles
  • Published:
Molecular Medicine Aims and scope Submit manuscript

Abstract

Background

Proteases facilitate several steps in cancer progression. To identify proteases most suitable for drug targeting, actual enzyme activity and not messenger RNA levels or immunoassay of protein is the ideal assay readout.

Materials and Methods

An automated microtiter plate assay format was modified to allow detection of all four major classes of proteases in tissue samples. Fifteen sets of colorectal carcinoma biopsies representing primary tumor, adjacent normal colon, and liver metastases were screened for protease activity.

Results

The major proteases detected were matrix metalloproteases (MMP9, MMP2, and MMP1), ca-thepsin B, cathepsin D, and the mast cell serine proteases, tryptase and chymase. Matrix metallopro-teases were expressed at higher levels in the primary tumor than in adjacent normal tissue. The mast cell proteases, in contrast, were at very high levels in adjacent normal tissue, and not detectable in the metastases. Cathepsin B activity was significantly higher in the primary tumor, and highest in the metastases. The major proteases detected by activity assays were then localized in biopsy sections by im-munohistochemistry. Mast cell proteases were abundant in adjacent normal tissue, because of infiltration of the lamina propria by mast cells. Matrix metalloproteases were localized to the tumor cells themselves; whereas, cathepsin B was predominantly expressed by macrophages at the leading edge of invading tumors. Although only low levels of urinary plasminogen activator were detected by direct enzyme assay, immunohistochemistry showed abundant protein within the tumor.

Conclusions

This analysis, surveying all major classes of proteases by assays of activity rather than immunolocalization or in situ hybridization alone, serves to identify proteases whose activity is not completely balanced by endogenous inhibitors and which may be essential for tumor progression. These proteases are logical targets for initial efforts to produce low molecular weight protease inhibitors as potential chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Imai K, Yokohama Y, Nakanishi I, et al. (1995) Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metallo-proteinases and enzymic properties. J. Biol. Chem. 270: 6691–6697.

    Article  CAS  PubMed  Google Scholar 

  2. Thewes M, Pohlmann G, Atkinson M, Mueller J, Putz B, Hofler H. (1996) Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations. Diagnostic Mol. Path. 5: 284–290.

    Article  CAS  Google Scholar 

  3. Campo E, Munoz J, Miquel R, et al. (1994) Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival [see comments]. Am. J. Path. 145: 301–309.

    PubMed  CAS  Google Scholar 

  4. Gallegos N, Smales C, Savage F, Hembry R, Bou-los P. (1995) The distribution of matrix metallo-proteinases and tissue inhibitor of metallopro-teinases in colorectal cancer. Surg. Oncol. 4: 111–119.

    Article  CAS  PubMed  Google Scholar 

  5. McDonnell S, Navre M, Coffey R, Matrisian L. (1995) Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol. Carcinogen. 4: 527–533.

    Article  Google Scholar 

  6. Murray G, Duncan M, O’Neil, Melvin W, Fothergill. (1996) Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nature Med. 2: 461–462.

    Article  CAS  PubMed  Google Scholar 

  7. Tran-Thang C, Kruithof E, Lahm H, Schuster WA, Tada M, Sordat B. (1996) Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Brit. J. Cancer 74: 846–852.

    Article  CAS  PubMed  Google Scholar 

  8. Buo L, Bjornland K, Karlsrud TS, et al. (1994) Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines. Anticancer Res. 14: 2445–2451.

    PubMed  CAS  Google Scholar 

  9. Stearns ME, Stearns M. (1996) Immunohisto-chemical studies of activated matrix metallopro-teinase-2 (MMP-2a) expression in human prostate cancer. Oncol. Res. 8: 63–67.

    PubMed  CAS  Google Scholar 

  10. Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. (1995) Immunohisto-chemical localization of cathepsin B in neoplas-tic human prostate. Prostate 26: 171–178.

    Article  CAS  PubMed  Google Scholar 

  11. Sinha AA, Gleason DF, Staley NA, Wilson MJ, Sameni M, Sloane BF. (1995) Cathepsin B in an-giogenesis of human prostate: an immunohisto-chemical and immunoelectron microscopic analysis. Anat. Rec. 241: 353–362.

    Article  CAS  PubMed  Google Scholar 

  12. Hoyhtya M, Fridman R, Komarek D, et al. (1994) Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Intl. J. Cancer 56: 500–505.

    Article  CAS  Google Scholar 

  13. Thewes M, Pohlmann G, Atkinson M, Mueller J, Putz B, Hofler H. (1996) Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations. Diag. Mol. Path. 5: 284–290.

    Article  CAS  Google Scholar 

  14. Johnson LD, Hunt DM, Kim K, Nachtigal M. (1996) Amplification of stromelysin-3 transcripts from carcinomas of the colon. Human Path. 27: 964–968.

    Article  CAS  Google Scholar 

  15. Miyajima Y, Nakano R, Morimatsu M. (1995) Analysis of expression of matrix metallopro-teinases-2 and −9 inhypopharyngeal squamous cell carcinoma by in situ hybridization. Ann. Otol. Rhinol. Laryngol. 104: 678–684.

    Article  CAS  PubMed  Google Scholar 

  16. Polette M, Clavel C, Birembaut P, De Clerck YA. (1993) Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Path. Res. Prac. 189: 1052–1057.

    Article  CAS  Google Scholar 

  17. Zeng Z, Guillem J. (1995) Distinct pattern of matrix metalloprotreinase-9 and tissue inhibitor of metalloproteinase-1 mRNA in human col-orectal cancer and liver metastases. Brit. J. Cancer 72: 575–582.

    Article  CAS  PubMed  Google Scholar 

  18. Murata M, Miyashita S, Yokoo C, et al. (1991) Novel epoxysuccinyl peptides. Fed. Eur. Biochem. Soc. 280: 307–310.

    Article  CAS  Google Scholar 

  19. Emmert-Buck MR, Roth MJ, Zhuang Z, et al. (1994) Increased gelatinase A (MMP-2) and 460 cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Path. 145: 1285–1290.

    PubMed  CAS  Google Scholar 

  20. Reddy VY, Zhang Q-Y, Weiss SJ. (1995) Pericel-lular mobilization of the tissue-destructive cys-teine proteases cathepsins B, L and S by human monocyte-derived macrophages. Proc. Natl. Acad. Sci. 92: 3849–3853.

    Article  CAS  PubMed  Google Scholar 

  21. Berquin IM, Sloane BF. (1996) Cathepsin B expression in human tumors. Adv. Exp. Med. Biol. 389: 281–294.

    Article  CAS  PubMed  Google Scholar 

  22. Meininger C. (1995) Mast cells and tumor-associated angiogenesis. In Marone G (ed.) Human Basophils and Mast Cells: Clinical Aspects. Kerger, Basel Switzerland, pp. 238–256.

    Google Scholar 

  23. Bashkin P, Razin E, Eldor A, Vlodavsky I. (1990) Degranulating mast cells secrete an en-doglycosidase which degrades heparin sulfate in subendothelial extracellular matrix. Blood 75: 2204–32212.

    PubMed  CAS  Google Scholar 

  24. Vlodavsky I, Eldor A, Haimovitz-Friedman A, et al. (1992) Expression of heparanase by platelets and circulating cells of the immune system: Possible involvement in diapedesis and extravasation. Inv. Metast. 12: 112–127.

    CAS  Google Scholar 

  25. Reed JA, Albino AP, McNutt NS. (1995) Human cutaneous mast cells express basic fibroblast growth factor. Lab. Invest. 72: 215–222.

    PubMed  CAS  Google Scholar 

  26. Grutzkau GA, Kruger-Krasagakes S, Baumeister H, et al. (1998) Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol. Biol. Cell. 9: 875–884.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Norrby K, Wooley DE. (1993) Role of mast cells in mitogenesis and angiogenesis in normal tissue and tumor tissue. Adv. Biosci. 89: 71–115.

    CAS  Google Scholar 

  28. Blair RJ, Meng H, Marchese MJ, et al. (1997) Human mast cells stimulate vascular tube formation. J. Clin. Invest. 99: 2691–2700.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Gruber BL, Kew RR, Jelaska A, et al. (1997) Human mast cells activate fibroblasts. J. Immunol. 158: 2310–2317.

    PubMed  CAS  Google Scholar 

  30. Fang K, Raymond WW, Blount J, Caughey GH. (1997): Dog mast cell a-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J. Biol. Chem. 272: 25628–25635.

    Article  CAS  PubMed  Google Scholar 

  31. Vu TV, Shipley JM, Bergers G, et al. (1998) Matrix metalloproteinase gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411–422.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors thank William Stetler-Stevenson, Bonnie Sloane, and Ellen Kick for reagents; the UCSF Liver Center Clinical Core for normal human liver samples; Mark Segal, Division of Biostatistics, UCSF, for consultation on statistical analysis; and Ramona Soto for preparation of the manuscript. This work was supported by a National Cancer Institute Program Project Grant #CA72006-02.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James H. McKerrow Ph.D., M.D..

Additional information

Communicated by F. E. Cohen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKerrow, J.H., Bhargava, V., Hansell, E. et al. A Functional Proteomics Screen of Proteases In Colorectal Carcinoma. Mol Med 6, 450–460 (2000). https://doi.org/10.1007/BF03401787

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401787

Keywords

Navigation